Cancer Research Technology
Log in Register
Menu

CXCR4-MOR Bivalent Ligand

Invented at Virginia Commonwealth University

Info

Catalogue Number 154267
Antigen/Gene or Protein Targets mu opioid receptor and C-X-C chemokine receptor 4
Relevance A novel bivalent ligand that contains two distinct pharmacophores linked through a spacer, one of which will interact with the mu opioid receptor (MOR) and the other with CXCr4. Naltrexone and It1t were selected as the pharmacophores to generate the bivalent probe.
Research Area Cell Signaling & Signal Transduction, Drug Discovery & Development

References

There are 0 reference entries for this reagent.

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor